Article focus {#section5-2046-3758.610.BJR-2017-0170}
=============

-   Large, publicly-funded, pragmatic multicentre trials such as the Proximal Fracture of the Humerus: Evaluation by Randomisation (PROFHER) trial involve very substantial investment. It is important to determine the impact of such endeavours.

-   This article reports the findings of an online survey completed by orthopaedic and trauma surgeons who treat patients with proximal humeral fractures in the United Kingdom.

-   The survey explored whether these surgeons had adopted the PROFHER trial results routinely into practice.

Key messages {#section6-2046-3758.610.BJR-2017-0170}
============

-   The survey showed that around half of the 265 respondents had changed practice because of PROFHER, with a third of those who had not changed already managing patients eligible for PROFHER non-operatively.

-   Qualitative analysis provided a more complex picture of the impact from PROFHER, such as in the use of evidence to underpin non-operative decisions.

-   The strongest overall message was the endorsement of evidence-based practice.

Strengths and limitations {#section7-2046-3758.610.BJR-2017-0170}
=========================

-   The survey obtained often detailed responses from a substantial number of orthopaedic surgeons who currently treat patients with fractures of the proximal humerus in the United Kingdom.

-   The actual response rate could not be calculated. Nonetheless, some evidence was available that provided reassurance in terms of adequate participation and low response bias.

-   The linked qualitative analysis informed and greatly enriched the interpretation of the quantitative data.

Introduction {#section8-2046-3758.610.BJR-2017-0170}
============

The Proximal Fracture of the Humerus: Evaluation by Randomisation (PROFHER) trial was a publicly funded, pragmatic, multicentre randomised controlled trial (RCT) that compared surgical treatment with non-surgical treatment for the majority of adults with displaced proximal humeral fractures involving the surgical neck.^[@bibr1-2046-3758.610.BJR-2017-0170]^ The trial inclusion criteria are shown in [Figure 1](#fig1-2046-3758.610.BJR-2017-0170){ref-type="fig"}. Between September 2008 and April 2011, 250 patients were recruited from 32 NHS hospitals in the United Kingdom. The main follow-up report, which was published in March 2015, showed no benefit of surgery over a two-year follow-up, when compared with non-surgical treatment for the study-defined fracture population.^[@bibr1-2046-3758.610.BJR-2017-0170]^ The study also showed significantly greater costs associated with surgical management.^[@bibr2-2046-3758.610.BJR-2017-0170]^ These findings have been incorporated into a guideline published in 2016 by the National Institute for Health and Care Excellence (NICE), which recommends that for adults "with displaced low energy proximal humerus fractures", "non-surgical management for definitive treatment of uncomplicated injuries" should be offered.^[@bibr3-2046-3758.610.BJR-2017-0170]^

![Proximal Fracture of the Humerus: Evaluation by Randomisation trial inclusion and exclusion criteria.](bonejointres-06-590-g001){#fig1-2046-3758.610.BJR-2017-0170}

Reflecting an ageing population, there is an increasing incidence of proximal humeral fractures,^[@bibr4-2046-3758.610.BJR-2017-0170]^ which already account for 5% to 6% of all adult fractures.^[@bibr5-2046-3758.610.BJR-2017-0170]^ The increasing but non-evidenced trend for surgical treatment,^[@bibr6-2046-3758.610.BJR-2017-0170]^ with an associated increase in direct treatment costs,^[@bibr7-2046-3758.610.BJR-2017-0170]^ and, crucially, an acknowledgement of collective equipoise by a substantial number of orthopaedic surgeons involved in treating these injuries, provided a suitable context for conducting PROFHER. Overall, PROFHER involved a substantial investment in terms of funding through the National Institute of Health Research (NIHR) and through contributions from hundreds of people, including surgeons and other clinicians at the participating sites. Given this substantial investment in research, the incorporation of research findings into NICE guidance and the continuing burden of these injuries on individuals and society, it is pertinent to explore whether, and in what way, the results of the study have affected surgeon decision-making.

Thus, we undertook a survey of orthopaedic surgeons with the primary objective of exploring whether there was awareness of the PROFHER trial results and whether these findings have been adopted routinely into clinical practice. This included identifying surgeons' treatment of these patients and the potential reasons for these treatment choices. In addition, we collected surgeons' views about other factors, including the reconfiguration of trauma services in the United Kingdom beginning in 2012 that may have influenced surgical practice more generally.

Materials and Methods {#section9-2046-3758.610.BJR-2017-0170}
=====================

Participants {#section10-2046-3758.610.BJR-2017-0170}
------------

In September 2016, surgeons were invited to participate in an online questionnaire via membership emails through the British Orthopaedic Association (BOA) and British Elbow and Shoulder Society (BESS). The email asked members to complete the questionnaire once, and only if they "currently treat patients for a proximal humerus fracture". A reminder email was sent to potential participants after two weeks. In order to improve response rates, participants were offered the opportunity to enter into a prize draw to win a £100 gift voucher upon questionnaire completion. A winner was chosen at random two weeks following closure of the online questionnaire.

Ethical approval was gained from the University of York Department of Health Sciences Research Governance Committee and permissions from BOA and BESS research committees before disseminating the survey. Surgeons were not obliged to take part in this study and were given the opportunity to withdraw at any time during completion of the online questionnaire.

Questionnaire {#section11-2046-3758.610.BJR-2017-0170}
-------------

Questionnaire items were generated through discussion between authors, which included expert researchers and a consultant orthopaedic surgeon who worked together on the PROFHER trial. The questionnaire draft was then piloted with a sample of six orthopaedic surgeons (members of BESS) in order to test the feasibility, ease of completion and face validity of questionnaire items prior to wider dissemination. A 'think aloud' process was undertaken,^[@bibr8-2046-3758.610.BJR-2017-0170]^ whereby each surgeon was asked to complete the questionnaire and talk through their responses with a researcher (LK) as they completed each item. By surgeons voicing their thought processes and meanings attributed to each question, the validity of the questionnaire items was tested to see how well these addressed the study objectives. This stage of the questionnaire testing also helped to identify any important omissions from the questionnaire items, and to record the length of time taken to complete the questionnaire.

The final questionnaire contained 29 items (summarised in [Fig. 2](#fig2-2046-3758.610.BJR-2017-0170){ref-type="fig"}) and was converted into electronic format using Qualtrics software (Provo, Utah). The survey, which took approximately ten minutes to complete, consisted of four sections. Sections 1 and 2 identified respondent demographics, experience levels and level of engagement in research generally. Section 3 explored in turn: respondents' current surgical practice in relation to all acute proximal humeral fractures, respondents' current treatment of patients with acute "low energy uncomplicated displaced fractures of the proximal humerus involving the surgical neck" and how much influence the PROFHER findings had on their practice. A final and optional section explored respondents' general thoughts on what may influence changes to surgical practice. In order to improve usability and reduce the time taken to complete the questionnaire, skip logic was used throughout, so that certain items only appeared based on participants' previous item responses. A progress bar, previous page facility, and 'save and resume later' function were also included to aid usability.

![Questionnaire items for this study (NIHR, National Institute for Health Research; PROFHER, Proximal Fracture of the Humerus: Evaluation by Randomisation; BESS, British Elbow and Shoulder Society).](bonejointres-06-590-g002){#fig2-2046-3758.610.BJR-2017-0170}

Statistical analysis {#section12-2046-3758.610.BJR-2017-0170}
--------------------

Descriptive statistics were used to summarise the characteristics of the sample (Sections 1 and 2), in total and grouped by whether participants did or did not change practice based on the PROFHER findings. Quantitative responses regarding current and changed treatment practices (Section 3) were summarised descriptively in total and grouped by selected sample characteristics (including surgical and research experience).

Qualitative analysis {#section13-2046-3758.610.BJR-2017-0170}
--------------------

Free-text responses were analysed qualitatively using principles of Framework Analysis,^[@bibr9-2046-3758.610.BJR-2017-0170]^ whereby key concepts and recurrent themes were generated through an iterative process of familiarisation with the data, coding, and recoding until a thematic framework emerged. Three researchers (LJ, HH and SB) with expertise in different areas (qualitative research, orthopaedic research and surgical trial design) coded the data with regular discussion. Due to the large amount of qualitative data yielded, numerical counting of themes occurring in participants' responses helped to explore trends.

Results {#section14-2046-3758.610.BJR-2017-0170}
=======

In total, 317 surgeons accessed the online questionnaire, which was sent out indiscriminately to an estimated 2600 surgeon members, some overlapping, of BOA and BESS. It is not possible to calculate a response rate, as respondents were asked to complete the questionnaire only if they were a practising surgeon who was currently treating patients with proximal humerus fractures. Of 317 respondents, 285 (89.9%) completed Section 1 and at least part of Section 2 and Section 3. The remaining 32 (10.1%) survey entries were excluded, as none of the questions had been completed (n = 29) or only those in Section 1 (basic demographics, n = 3).

The study's prime question of interest ("Have you changed your practice within the last couple of years in terms of surgical treatment for these fractures?") was answered (Yes/No) in 265 questionnaires (93.0% of 285); these were therefore included in the main analysis. The 20 participants who did not answer this question tended to be younger, less likely to be specialised in trauma or shoulder surgery, and have fewer years of experience.

Participant characteristics {#section15-2046-3758.610.BJR-2017-0170}
---------------------------

[Table I](#table1-2046-3758.610.BJR-2017-0170){ref-type="table"} shows that most participants were aged between 36 and 55 years old (70.2%), were male (94.0%), worked in England (83.6%) and worked in a trauma unit (65.0%). Just over half were specialised shoulder surgeons (54.3%), mainly of consultant grade (82.9%) and with over ten years of experience in treating proximal humeral fractures (59.6%).

###### 

Characteristics of participants who did/did not change practice because of the Proximal Fracture of the Humerus: Evaluation by Randomisation trial. Missing responses are excluded from all percentage calculations

  Characteristic                                                                 Changed practice (n = 137)   Did not change practice (n = 128)   Total (n = 265)
  ------------------------------------------------------------------------------ ---------------------------- ----------------------------------- -----------------
  **Age (yrs)**, n (%)                                                                                                                            
  ⩽ 35                                                                           17 *(12.4)*                  6 *(4.7)*                           23 *(8.7)*
  36 to 45                                                                       52 *(38.0)*                  46 *(35.9)*                         98 *(37.0)*
  46 to 55                                                                       44 *(32.1)*                  44 *(34.4)*                         88 *(33.2)*
  56 to 65                                                                       23 *(16.8)*                  31 *(24.2)*                         54 *(20.4)*
  ⩾ 66                                                                           1 *(0.7)*                    1 *(0.8)*                           2 *(0.8)*
  Missing                                                                        0                            0                                   0
  **Gender**, n (%)                                                                                                                               
  Male                                                                           126 *(92.0)*                 123 *(96.1)*                        249 *(94.0)*
  Female                                                                         11 *(8.0)*                   5 *(3.9)*                           16 *(6.0)*
  Missing                                                                        0                            0                                   0
  **Country of work**, n (%)                                                                                                                      
  England                                                                        112 *(81.8)*                 107 *(85.6)*                        219 *(83.6)*
  Scotland                                                                       9 *(6.6)*                    7 *(5.6)*                           16 *(6.1)*
  Wales                                                                          10 *(7.3)*                   4 *(3.2)*                           14 *(5.3)*
  Northern Ireland                                                               4 *(2.9)*                    6 *(4.8)*                           10 *(3.8)*
  Other^[\*](#table-fn1-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}^       2 *(1.5)*                    1 *(0.8)*                           3 *(1.1)*
  Missing                                                                        0                            3                                   3
  **Place of work**, n (%)                                                                                                                        
  Major Trauma Centre (England) or equivalent tertiary hospital                  28 *(20.4)*                  37 *(29.4)*                         65 *(24.7)*
  Trauma Unit (England) or equivalent secondary care hospital                    96 *(70.1)*                  75 *(59.5)*                         171 *(65.0)*
  District General Hospital                                                      8 *(5.8)*                    9 *(7.1)*                           17 *(6.5)*
  Other^[†](#table-fn2-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}^        5 *(3.6)*                    5 *(4.0)*                           10 *(3.8)*
  Missing                                                                        0                            2                                   2
  **Role**, n (%)                                                                                                                                 
  General orthopaedic surgeon                                                    48 *(35.0)*                  46 *(35.9)*                         94 *(35.5)*
  Trauma surgeon                                                                 10 *(7.3)*                   17 *(13.3)*                         27 *(10.2)*
  Shoulder surgeon                                                               79 *(57.7)*                  65 *(50.8)*                         144 *(54.3)*
  Missing                                                                        0                            0                                   0
  **Clinical post held, n (%)**                                                                                                                   
  Consultant                                                                     111 *(81.6)*                 107 *(84.3)*                        218 *(82.9)*
  Specialty Trainee, ST7 or ST8                                                  10 *(7.4)*                   8 *(6.3)*                           18 *(6.8)*
  Specialty Trainee, ST1 to ST6                                                  7 *(5.1)*                    4 *(3.1)*                           11 *(4.2)*
  Staff and Associate specialists                                                4 *(2.9)*                    6 *(4.7)*                           10 *(3.8)*
  Fellows                                                                        4 *(2.9)*                    2 *(1.6)*                           6 *(2.3)*
  Missing                                                                        1                            1                                   2
  **Years of experience in treating fractures of the proximal humerus, n (%)**                                                                    
  0 to 5                                                                         15 *(10.9)*                  10 *(7.8)*                          25 *(9.4)*
  6 to 10                                                                        49 *(35.8)*                  33 *(25.8)*                         82 *(30.9)*
  11 to 15                                                                       26 *(19.0)*                  31 *(24.2)*                         57 *(21.5)*
  16 to 20                                                                       19 *(13.9)*                  22 *(17.2)*                         41 *(15.5)*
  ⩾ 21                                                                           28 *(20.4)*                  32 *(25.0)*                         60 *(22.6)*
  Missing                                                                        0                            0                                   0

the three respondents who chose 'Other' for this question worked in France, Singapore and the United States, respectively

'Other' here referred, for example, to private centres and university hospitals

Survey results {#section16-2046-3758.610.BJR-2017-0170}
--------------

Of the 265 participants included in the analysis, 137 (51.7%) had changed their practice in terms of surgical treatment of acute displaced proximal humeral fractures entirely (90 responses) or partly (47 responses) because of the PROFHER findings. In comparison, 128 participants (48.3%) did not change practice because of PROFHER, although three had changed practice for other reasons. However, of these 128 respondents, free-text responses revealed that 43 surgeons were already managing these types of patients non-operatively; for example: "I already practised along the lines of the PROFHER findings".

Comparison of participants who did or did not change practice because of PROFHER {#section17-2046-3758.610.BJR-2017-0170}
--------------------------------------------------------------------------------

Surgeons who changed practice tended to be slightly younger, working in a trauma unit rather than a major trauma centre, be a shoulder surgeon rather than a trauma surgeon and have fewer years of experience in treating these fractures ([Table I](#table1-2046-3758.610.BJR-2017-0170){ref-type="table"}).

[Table II](#table2-2046-3758.610.BJR-2017-0170){ref-type="table"} summarises the clinicians' prior involvement in research, direct involvement with the PROFHER trial and perceived validity and applicability of the PROFHER findings. Surgeons who changed their practice were more likely to have had a substantive role, mainly as Principal Investigator (PI), in an NIHR randomised surgical trial in the past (19.7% *versus* 8.7%). Overall, 39 participants (14.7%) had participated in the PROFHER trial, nine as PIs. Participation did not appear to be related to subsequent change in practice.

###### 

Research engagement of participants who did/did not change practice because of the Proximal Fracture of the Humerus: Evaluation by Randomisation (PROFHER). Missing responses are excluded from all percentage calculations

                                                                                                                                                            Changed practice (n = 137)   Did not change practice (n = 128)   Total (n = 265)
  --------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- ----------------------------------- -----------------
  **Substantive role in an NIHR randomised controlled surgical trial**, n (%)                                                                                                                                                
  Yes                                                                                                                                                       27 *(19.7)*                  11 *(8.7)*                          38 *(14.3)*
  No                                                                                                                                                        110 *(80.3)*                 116 *(91.3)*                        226 *(85.6)*
  Missing                                                                                                                                                   0                            1                                   1
  **Role held**, n (%)^[\*](#table-fn3-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}[†](#table-fn4-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}^                                                                    
  Principal Investigator (PI)                                                                                                                               21 *(91.3)*                  8 *(88.9)*                          29 *(90.6)*
  Chief Investigator                                                                                                                                        1 *(4.3)*                    0 *(0.0)*                           1 *(3.1)*
  Co-applicant                                                                                                                                              2 *(8.7)*                    0 *(0.0)*                           2 *(6.3)*
  Member of oversight committee                                                                                                                             3 *(13.0)*                   1 *(11.1)*                          4 *(12.5)*
  Missing                                                                                                                                                   4                            2                                   6
  **Participation in the PROFHER trial**, n (%)                                                                                                                                                                              
  Yes                                                                                                                                                       22 *(16.1)*                  17 *(13.3)*                         39 (14.7)
  No                                                                                                                                                        115 *(83.9)*                 111 *(86.7)*                        226 (85.3)
  Missing                                                                                                                                                   0                            0                                   0
  **PI for a PROFHER site**, n (%)^[‡](#table-fn5-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}^                                                                                                                         
  Yes                                                                                                                                                       5 *(22.7)*                   4 *(23.5)*                          9 *(23.1)*
  No                                                                                                                                                        17 *(77.3)*                  13 *(76.5)*                         30 *(76.9)*
  Missing                                                                                                                                                   0                            0                                   0
  **Awareness of the PROFHER findings**, n (%)                                                                                                                                                                               
  Yes                                                                                                                                                       134 *(97.8)*                 111 *(86.7)*                        245 *(92.5)*
  No                                                                                                                                                        3 *(2.2)*                    17 *(13.3)*                         20 *(7.5)*
  Missing                                                                                                                                                   0                            0                                   0
  **Where heard about PROFHER**, n (%)^[\*](#table-fn3-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}§^                                                                                                                   
  Attended a meeting where the results of PROFHER were presented                                                                                            105 *(78.4)*                 70 *(63.1)*                         175 *(71.4)*
  Read one or more of the research publications                                                                                                             94 *(70.1)*                  77 *(69.4)*                         171 *(69.8)*
  Through working at a participating site                                                                                                                   19 *(14.2)*                  15 *(13.5)*                         34 *(13.9)*
  Local contacts                                                                                                                                            38 *(28.4)*                  26 *(23.4)*                         64 *(26.1)*
  NICE guidelines                                                                                                                                           19 *(14.2)*                  13 *(11.7)*                         32 *(13.1)*
  Missing                                                                                                                                                   0                            0                                   0
  **Validity of PROFHER findings (0 to 10)**^[\*](#table-fn3-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}^                                                                                                              
  Mean ([sd]{.smallcaps})                                                                                                                                   7.4 (1.7)                    5.3 (2.4)                           6.4 (2.3)
  Median (range)                                                                                                                                            7 (0 to 10)                  6 (0 to 10)                         7 (0 to 10)
  Missing                                                                                                                                                   0                            0                                   0
  **Applicability of PROFHER findings to own practice (0 to 10)**^[\*](#table-fn3-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}^                                                                                         
  Mean ([sd]{.smallcaps})                                                                                                                                   7.6 (1.7)                    5.6 (2.6)                           6.7 (2.4)
  Median (range)                                                                                                                                            8 (1 to 10)                  6 (0 to 10)                         7 (0 to 10)
  Missing                                                                                                                                                   0                            0                                   0

more than one response was possible for this question

this total is based on the 38 participants who had a substantive role in a NIHR randomised controlled surgical trial

this total is based on the 39 participants who had participated in the PROFHER trial

§this total is based on the 245 participants who were aware of the PROFHER findings; 111 changed their practice because of PROFHER; 112 did not change their practice

NIHR, National Institute for Health Research; NICE, National Institute for Health and Care Excellence

The majority of participants (245; 92.5%) were aware of the PROFHER findings before reading the research summary reported in the first page of the survey. Awareness was less in the group who did not change practice (86.7%). Curiously, three participants who reported to have changed practice because of PROFHER reported not to have been aware of it. Most participants heard about the trial results in meetings where these were presented (71.1%) and/or read them in one or more research publication (69.8%). Participants who changed their practice were more likely to have attended a meeting (78.4% *versus* 62.5%).

Participants who changed their surgical practice gave higher ratings (out of 10) to the validity of the PROFHER results (mean 7.4 *versus* 5.3) and the applicability of results to their own practice (mean 7.6 *versus* 5.6) than participants who did not change practice. There was greater variability in both scores among participants who did not change practice; this included all six instances of zero scores for both items.

Surgeons who did not change practice operated on a greater number of proximal humeral fractures (all types) and acute 'uncomplicated' displaced fractures of the proximal humerus involving the surgical neck (as eligible for the PROFHER trial) between April 2015 and March 2016 than those who did change practice ([Table III](#table3-2046-3758.610.BJR-2017-0170){ref-type="table"}). A low number of PROFHER-eligible fractures (frequency category 0 to 5) were operated on by 81.6% of surgeons who changed practice and 68.8% of surgeons who did not. None of the surgeons who changed practice operated on more than 15 PROFHER-eligible fractures.

###### 

Fracture treatment of participants who did*/*did not change practice because of the Proximal Fracture of the Humerus: Evaluation by Randomisation (PROFHER) trial

                                                                                                        Changed practice (n = 137)   Did not change practice (n = 128)   Total (n = 265)
  ----------------------------------------------------------------------------------------------------- ---------------------------- ----------------------------------- -----------------
  **Proximal humeral fractures (all types) operated in the last year, n (%)**                                                                                            
  0 to 5                                                                                                69 *(50.4)*                  51 *(39.8)*                         120 *(45.3)*
  6 to 10                                                                                               34 *(24.8)*                  28 *(21.9)*                         62 *(23.4)*
  11 to 15                                                                                              18 *(13.1)*                  19 *(14.8)*                         37 *(14.0)*
  16 to 20                                                                                              12 *(8.8)*                   15 *(11.7)*                         27 *(10.2)*
  20+                                                                                                   4 *(2.9)*                    14 *(10.9)*                         18 *(6.8)*
  Don't know                                                                                            0 *(0.0)*                    1 *(0.8)*                           1 *(0.4)*
  Missing                                                                                               0                            0                                   0
  **Surgical methods used**, n (%)^[\*](#table-fn8-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}^                                                                    
  Locking plate                                                                                         111 *(81.0)*                 107 *(83.6)*                        218 *(82.3)*
  Intramedullary nail                                                                                   37 *(27.0)*                  49 *(38.3)*                         86 *(32.5)*
  Hemiarthroplasty                                                                                      69 *(50.4)*                  65 *(50.8)*                         134 *(50.6)*
  Reverse shoulder arthroplasty                                                                         62 *(45.3)*                  43 *(33.6)*                         105 *(39.6)*
  Other^[†](#table-fn9-2046-3758.610.BJR-2017-0170){ref-type="table-fn"}^                               8 *(5.8)*                    6 *(4.7)*                           14 *(5.3)*
  Missing                                                                                               0                            0                                   0
  **Fractures operated that were eligible for the PROFHER trial, n (%)**                                                                                                 
  0 to 5                                                                                                111 *(81.6)*                 88 *(68.8)*                         199 *(75.4)*
  6 to 10                                                                                               13 *(9.6)*                   17 *(13.3)*                         30 *(11.4)*
  11 to 15                                                                                              7 *(4.4)*                    12 *(9.4)*                          18 *(6.8)*
  16 to 20                                                                                              0 *(0.0)*                    3 *(2.3)*                           3 *(1.1)*
  20+                                                                                                   0 *(0.0)*                    3 *(2.3)*                           3 *(1.1)*
  Don't know                                                                                            6 *(4.4)*                    5 *(3.9)*                           11 *(4.2)*
  Missing                                                                                               1                            0                                   1
  **Impact of the PROFHER cost-effectiveness findings on decision-making, n (%)**                                                                                        
  Very influential                                                                                      8 *(6.0)*                    2 *(1.6)*                           10 *(3.9)*
  Influential                                                                                           32 *(23.9)*                  7 *(5.7)*                           39 *(15.2)*
  Somewhat influential                                                                                  47 *(35.1)*                  47 *(38.2)*                         94 *(36.6)*
  Not at all influential                                                                                47 *(35.1)*                  67 *(54.5)*                         114 *(44.4)*
  Missing                                                                                               3                            5                                   8
  **External changes to service delivery**, n (%)                                                                                                                        
  Yes                                                                                                   21 *(15.8)*                  17 *(14.0)*                         38 *(15.0)*
  No                                                                                                    112 *(84.2)*                 104 *(86.0)*                        216 *(85.0)*
  Missing                                                                                               4                            7                                   11

more than one response was possible for this question

examples of responses to this question include: "Isolated tuberosity repair like cuff repair -- sutures and anchors"; "intramedullary wires"; "intramedullary strut"; "T Plate"; and "LCDPlates"

The most popular surgical technique was fixation by locking plate (82.3% overall). Participants who changed practice were more likely to use reverse shoulder arthroplasty (45.3% *versus* 33.6%) and less likely to use intramedullary nails (27.0% *versus* 38.3%) than participants who did not change practice.

Participants who changed their practice were more likely to consider the PROFHER cost-effectiveness findings as "very influential" or "influential" than in those who did not (29.9% *versus* 7.3%).

A total of 38 respondents (15.0%) indicated there had been external changes that had impacted on their current practice. Statements supplied by 37 of these indicated two main categories. The first related to changes to the delivery of trauma services, usually reflecting local availability of specialist colleagues (18 responses). The second (12 responses) indicated service pressures ("very busy trauma lists", bed and theatre availability issues) in various ways that impacted on surgical practice.

Qualitative results {#section18-2046-3758.610.BJR-2017-0170}
-------------------

The qualitative analysis of free-text data relating to change in practice was divided into groups of those participants who had or had not changed their practice because of PROFHER. The results of the fourth section of the survey, which explored wider factors affecting change in practice through free-text responses, are presented separately. In the following, we present the key emerging themes relating to these two aspects.

Respondents who had changed practice relating to PROFHER {#section19-2046-3758.610.BJR-2017-0170}
--------------------------------------------------------

All 137 respondents who indicated that they had changed practice provided further information about these changes through free-text responses. Most of these responses purely indicated a general move towards a more conservative approach. Where further information was offered, many highlighted how the PROFHER trial findings had given them greater confidence in making a decision to treat non-operatively (22 cases). Others suggested they had already been using conservative treatment for these patients (39 cases) and, in some instances, respondents commented that this had reduced concerns around liability as their practice was now evidence-based.

Several respondents indicated that they used the trial findings to inform a patient-centred approach, for example, through discussions of treatment options with patients in light of the trial findings (21 cases). Meanwhile, others commented on the need to review patients' need for surgery on a case-by-case basis (24 cases), with specific exclusion criteria from the PROFHER trial being important in these decisions (e.g. intra-articular extension or associated dislocation). Although not an exclusion criteria in the PROFHER trial, age was a consideration for some respondents, who generally stated that they only considered operating on younger patients. In some instances, respondents gave examples of how their surgical approach had altered over recent years; for example, a reduction in the use of locking plates was observed.

The influence of wider opinion, such as colleagues' change in practice, had apparently affected treatment decisions for some respondents. In some instances, respondents who were not specific shoulder specialists reported that the trial findings had led them to make fewer referrals to their specialist colleagues (nine cases). However, one respondent raised concerns that the trial findings may be misinterpreted by non-specialists, leading to reductions in referrals. Three respondents who had originally changed their practice in light of the PROFHER findings had reverted back to surgical management due to concerns around poorer outcomes from non-operative care; one indicating that "\[the\] study findings are not replicated in our population".

Of those giving specific reasons as to how the PROFHER trial findings had prompted a change in practice, many were encouraged to change practice due to there being no difference in patient outcomes across treatment groups, as well as the greater costs and potential for harm associated with surgery. Several respondents commented on the definitive nature of the trial findings, which had provided high-quality evidence to support these decisions. In a handful of cases where respondents had "partly changed" their practice, respondents were negative about the trial results, citing concerns around validity, sample size or preferring to rely on 'gut instinct' when treating patients.

Respondents who had not changed practice relating to PROFHER {#section20-2046-3758.610.BJR-2017-0170}
------------------------------------------------------------

The responses of the 111 respondents providing further information as to why they had not changed their practice as a result of the PROFHER trial fell into three broad categories: those indicating that the respondents were already managing these patients conservatively (43 cases); those critical about the study (33 cases); and heterogeneous comments that could not be grouped into an overarching theme (35 cases). Of note was that, similar to the respondents who had changed their practice, respondents commented that the PROFHER results had given greater support when considering non-surgical management (19 cases) and had additionally aided discussions with patients (eight cases).

Of those 43 respondents indicating they were already managing patients conservatively, similar comments emerged as to the group who had indicated their practice had changed in recent years (described earlier). For example, many commented on the greater confidence in treating non-operatively now, some with fewer referrals to specialist colleagues. Likewise, several stressed the need to review patients on a case-by-case basis, with surgery being offered for fractures excluded from the PROFHER trial in four cases. Of the 33 expressing some criticism or reservation with the PROFHER trial, there were ten respondents who were highly critical of the study (4% of total sample). These responses corresponded to very low scores, typically 0, for the questionnaire items exploring perceived validity and applicability. Critical comments were mostly specific in nature, airing concerns about potential sources of bias such as selection bias (e.g. surgeons' ability to exclude those patients with a clear indication for surgery), generalisability of the study findings (e.g. exclusion of complex fractures; lack of reverse shoulder arthroplasties), or concerns around study design (several relating to the pragmatic study design).

In terms of heterogeneous comments that were not grouped into one overarching theme, these comments related to respondents' continuing reliance on their own judgement and professional experience that did not reflect the results of PROFHER and consequently led to a tendency for preferring surgical management.

General thoughts about factors influencing change in practice {#section21-2046-3758.610.BJR-2017-0170}
-------------------------------------------------------------

Section 4 of the survey prompted free-text responses to three questions relating to factors influencing practice, with an option for further comments ([Fig. 2](#fig2-2046-3758.610.BJR-2017-0170){ref-type="fig"}). This optional section was completed by 136 respondents (51.1%); more of whom changed practice (56.2%, 77 of 137) than did not (47.7%, 59 of 129).

The need for an evidence base was the predominant response (110 cases) to the question asking "what factors are likely to influence your decision to change surgical practice?" The surgeons' own experience (30 cases) and peers' opinions (19 cases) were also expressed as important drivers for changing practice, with costs, choice of outcome measure used in research and needs of patients, including safety, featuring to lesser extents. For the second question, the majority considered that "practising EBM was becoming the norm in orthopaedic surgery", either fully (52 cases), partly (15 cases) or at least on the way (23 cases), with several respondents pointing to limitations in the available evidence (17 cases). A total of 20 respondents considered that it was not the norm.

Several themes arose from the responses on what the respondent's specialist society (e.g. BESS, BOA, British Society for Surgery of the Hand, Royal College of Surgeons) could do to guide change in their practice. One strong theme was the production of evidence-based guidelines, guidance (including standards) and summaries (including evidence updates and reviews) for information, to help and support decision-making (46 cases). This often linked with dissemination (24 cases), including at meetings in several cases. Several emphasised the need for critical appraisal. A second strong theme was society support, promotion, funding, and dissemination of research, mainly multicentre RCTs (29 cases), but also of other research that included epidemiology of conditions, national registries and identifying key clinical questions. Several directly endorsed the current activities, often specifically the support for large RCTs, of their specialist society (19 cases). There were a few exceptions, including those stressing the need to avoid the influence of industry.

Finally, when given the option of recording further comments, responses re-iterated the themes that had emerged mostly around the importance of the need for an evidence base and support for PROFHER, but also reservations about the limitations of the current evidence.

Discussion {#section22-2046-3758.610.BJR-2017-0170}
==========

This survey, which includes complete responses from 265 orthopaedic and trauma surgeons who are currently treating patients with proximal humerus fracture, confirms that the findings of the PROFHER trial have been well disseminated and have been considered by the United Kingdom's orthopaedic community in terms of their clinical practice. Around half (137) of these respondents had changed practice to various extents because of PROFHER, principally in that they treated fewer PROFHER-eligible fractures surgically. A third (43) of the 128 respondents who had not changed practice were already managing patients consistent with the PROFHER findings, thus primarily non-operatively. The data suggest some differences in characteristics of the surgeons who did or did not change practice because of PROFHER; most notably those who changed practice were younger, worked in a trauma unit rather than a major trauma centre and were shoulder surgeons. This group gave higher scores when assessing validity and applicability of PROFHER. In contrast, a quarter of the non-changers were critical, sometimes emphatically, of PROFHER. The strongest message from the 136 participants who completed the section on general factors influencing change in practice was the endorsement of evidence-based orthopaedic practice.

This large, anonymous survey obtains both quantitative and qualitative data from the two main professional societies of surgeons operating on these fractures in the United Kingdom. The lack of the key denominator (all United Kingdom surgeons who were treating proximal humeral fractures at the time of the survey) means we cannot provide a response rate. Of note, however, is that the 144 shoulder surgeons who participated in the survey are likely to feature among the 550 shoulder and elbow surgeon members of BESS in 2017. Secondly, our analysis is based on data from 83.6% (265 of 317 accesses) of those who accessed the website. Exploring possible response bias, we find that 39 respondents (15%) had participated in the PROFHER trial (equating to 45% of 87 named surgeons who assessed eligibility and including nine PIs of 35 recruiting sites).^[@bibr10-2046-3758.610.BJR-2017-0170]^ There was, therefore, a substantial response to the survey beyond those surgeons who were actively involved in the trial. Notably, whether surgeons participated or not in PROFHER did not influence the proportion who did and did not change practice.

Encouragingly, with the 265 orthopaedic and trauma surgeons responding to the survey, this emphasises the substantial interest in the findings of the trial beyond those involved in PROFHER. Another limitation of our survey is the lack of exact data to quantify the impact of PROFHER. Matching our experience with collecting this data in the trial itself, very few respondents gave an exact number of operations for proximal humeral fractures or for PROFHER eligible fractures they conducted over a one-year period. Nonetheless, the survey results supported a move towards non-surgical treatment because of the PROFHER results and, notably, a strong qualitative theme was the use of the PROFHER findings to support non-operative decisions, including helping discussions with patients.

This survey is one of various approaches to measuring impact of trials such as PROFHER. An intended repeat of the study by Dean et al^[@bibr11-2046-3758.610.BJR-2017-0170]^ that reviewed surgical practice in 11 United Kingdom hospitals between January 2014 and March 2015, thus before the *Journal of the American Medical Association* publication of PROFHER,^[@bibr1-2046-3758.610.BJR-2017-0170]^ will be valuable. However, as illustrated for the Distal Radius Acute Fracture Fixation Trial, using the date of main publication as the threshold for detecting change may be misleading.^[@bibr12-2046-3758.610.BJR-2017-0170]^ For PROFHER, several United Kingdom surgeons would have been aware of the main finding in the year before this as a result of presentations at meetings. Further complexity arises from evolving practice, crucially the increasing use of reverse shoulder arthroplasty (RSA) for more complex types of these fractures in older people corroborated in this survey and elsewhere.^[@bibr11-2046-3758.610.BJR-2017-0170]^ This has prompted the proposal for 'PROFHER-2', another multicentre trial that aims to examine the role of RSA for 3 and 4 part fractures in older patients.

The key finding from this survey is that PROFHER, a large, publicly funded, pragmatic randomised trial, has had an impact on surgeons' clinical practice, both changing it and underpinning existing non-operative practice. A potentially more important finding of the survey is the endorsement of evidence-based practice, and the active engagement of orthopaedic surgeons in multicentre clinical trials, which confirms a major phase change in the United Kingdom orthopaedic community. Indeed, the successful delivery by the orthopaedic surgeon community of PROFHER may be the most lasting impact of PROFHER, as it showed what is possible in terms of both the need for future research and the advancement of surgical knowledge and patient care.
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